|
US20020168718A1
(en)
*
|
1997-04-03 |
2002-11-14 |
California Institute Of Technology |
Enzyme-mediated modification of fibrin for tissue engineering
|
|
US7601685B2
(en)
*
|
1998-08-27 |
2009-10-13 |
Eidgenossische Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
US6958212B1
(en)
*
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
|
WO2000044808A1
(en)
|
1999-02-01 |
2000-08-03 |
Hubbell Jeffrey A |
Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
|
|
US7144991B2
(en)
|
1999-06-07 |
2006-12-05 |
Aletheon Pharmaceuticals, Inc. |
Streptavidin expressed gene fusions and methods of use thereof
|
|
AU5597500A
(en)
*
|
1999-06-07 |
2000-12-28 |
Neorx Corporation |
Streptavidin expressed gene fusions and methods of use thereof
|
|
US7291673B2
(en)
*
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
|
JP4560291B2
(ja)
*
|
2001-12-18 |
2010-10-13 |
イジュノシッヒ テクニッヒ ホッフシューラ チューリッヒ |
組織操作のための成長因子改変タンパク質マトリクス
|
|
US7247609B2
(en)
*
|
2001-12-18 |
2007-07-24 |
Universitat Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
EP1465989B1
(en)
*
|
2001-12-18 |
2008-02-20 |
Eidgenossisch Technische Hochschule Zurich |
Growth factor modified protein matrices for tissue engineering
|
|
US8282912B2
(en)
*
|
2002-03-22 |
2012-10-09 |
Kuros Biosurgery, AG |
Compositions for tissue augmentation
|
|
US8399400B2
(en)
|
2004-12-01 |
2013-03-19 |
Syntaxin, Ltd. |
Fusion proteins
|
|
US8778634B2
(en)
|
2004-12-01 |
2014-07-15 |
Syntaxin, Ltd. |
Non-cytotoxic protein conjugates
|
|
US8603779B2
(en)
|
2004-12-01 |
2013-12-10 |
Syntaxin, Ltd. |
Non-cytotoxic protein conjugates
|
|
GB0426394D0
(en)
*
|
2004-12-01 |
2005-01-05 |
Health Prot Agency |
Fusion proteins
|
|
US8512984B2
(en)
|
2004-12-01 |
2013-08-20 |
Syntaxin, Ltd. |
Non-cytotoxic protein conjugates
|
|
JP2008529972A
(ja)
*
|
2004-12-22 |
2008-08-07 |
クロス・バイオサージェリー・アクチェンゲゼルシャフト |
酵素的に分解可能な連結を通じて生物活性因子が組み入れられている合成バイオマテリアル
|
|
US8575101B2
(en)
|
2005-01-06 |
2013-11-05 |
Kuros Biosurgery Ag |
Supplemented matrices for the repair of bone fractures
|
|
ES2902872T3
(es)
*
|
2005-01-06 |
2022-03-30 |
Kuros Biosurgery Ag |
Matrices suplementadas para la reparación de fracturas óseas
|
|
WO2006073711A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Kuros Biosurgery Ag |
Use of a matrix comprising a contrast agent in soft tissues
|
|
GB0610867D0
(en)
*
|
2006-06-01 |
2006-07-12 |
Syntaxin Ltd |
Treatment of pain
|
|
PL2136850T3
(pl)
|
2007-04-13 |
2012-07-31 |
Kuros Biosurgery Ag |
Polimeryczny uszczelniacz tkankowy
|
|
WO2009083544A2
(en)
|
2007-12-28 |
2009-07-09 |
Kuros Biosurgery Ag |
Pdgf fusion proteins incorporated into fibrin foams
|
|
PE20120591A1
(es)
|
2009-04-02 |
2012-05-23 |
Roche Glycart Ag |
Anticuerpos multiespecificos que comprenden anticuerpos de longitud completa y fragmentos fab de cadena sencilla
|
|
WO2011034605A2
(en)
*
|
2009-09-16 |
2011-03-24 |
Genentech, Inc. |
Coiled coil and/or tether containing protein complexes and uses thereof
|
|
AR080793A1
(es)
|
2010-03-26 |
2012-05-09 |
Roche Glycart Ag |
Anticuerpos biespecificos
|
|
RU2013110875A
(ru)
|
2010-08-24 |
2014-09-27 |
Ф.Хоффманн-Ля Рош Аг |
БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА, СОДЕРЖАЩИЕ СТАБИЛИЗИРОВАННЫЙ ДИСУЛЬФИДОМ ФРАГМЕНТ Fv
|
|
JP5766296B2
(ja)
|
2010-12-23 |
2015-08-19 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
|
|
EP2678002A2
(en)
|
2011-02-25 |
2014-01-01 |
Medtronic, Inc. |
Therapy for kidney disease and/or heart failure
|
|
WO2012123028A1
(en)
|
2011-03-16 |
2012-09-20 |
Kuros Biosurgery Ag |
Pharmaceutical formulation for use in spinal fusion
|
|
US20130244937A1
(en)
|
2011-09-02 |
2013-09-19 |
Nile Therapeutics, Inc. |
Chimeric natriuretic peptide compositions and methods of preparation
|
|
MX2014009565A
(es)
|
2012-02-10 |
2014-11-10 |
Genentech Inc |
Anticuerpos monocatenarios y otros heteromultimeros.
|
|
RU2015100656A
(ru)
|
2012-06-27 |
2016-08-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения
|
|
JP6203838B2
(ja)
|
2012-06-27 |
2017-09-27 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
少なくとも２つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
|
|
US20140056870A1
(en)
|
2012-08-27 |
2014-02-27 |
Allergan, Inc. |
Fusion proteins
|
|
WO2016087416A1
(en)
|
2014-12-03 |
2016-06-09 |
F. Hoffmann-La Roche Ag |
Multispecific antibodies
|